News

Archives

• 2021
  • Jun (1)
    • Congratulations! We have completed our recruitment target of 1587 randomization on 30 June 2021!
  • May (1)
    • We have reached 1569 by March 2021!
  • Jan (1)
    • We have reached 1553 by December 2020!
• 2020
  • Oct (1)
    • We have reached 1538 by September 2020!
  • Jul (1)
    • We have reached 1510 by June 2020!
  • Apr (1)
    • 1st Quarter 2020
• 2019
  • Dec (1)
    • 4th Quarter 2019
  • Oct (1)
    • 3rd Quarter 2019
  • Jul (1)
    • 2nd Quarter 2019
  • Apr (1)
    • 1st Quarter 2019
  • Jan (1)
    • 4th Quarter 2018
• 2018
  • Oct (1)
    • 3rd Quarter 2018
  • Jul (1)
    • 2nd Quarter 2018
  • Apr (1)
    • 1st Quarter 2018
  • Jan (1)
    • We reached our 1200 randomized subjects!
• 2017
  • Oct (1)
    • 3rd Quarter 2017
  • Jul (1)
    • 2nd Quarter 2017
  • Apr (1)
    • We reach our 1000 randomized subject!
  • Jan (1)
    • 4th Quarter 2016
• 2016
  • Oct (1)
    • 3rd Quarter 2016
  • Apr (2)
    • 1st Quarter 2016
    • 2nd Quarter 2016
  • Jan (1)
    • 4th Quarter 2015
• 2015
  • Oct (1)
    • 3rd Quarter 2015
  • Jul (1)
    • 2nd Qtr 2015 Site Activation and 1st Recruitment
  • Apr (1)
    • 1st Qtr 2015 Site Activation and Recruitment
  • Jan (1)
    • 4th Quarter 2014 Site Activation and Recruitment
• 2014
  • Oct (1)
    • 3rd Quarter 2014 Site Activation and Randomization
  • Jul (1)
    • 2nd Quarter 2014 Site Activation and Randomization
  • Apr (1)
    • 1st Quarter 2014 SIV and Randomization
  • Jan (2)
    • 4th Qtr 2013 New Site SIV and Site's 1st Randomization in China
    • AGITG awarded grant
• 2013
  • Oct (1)
    • ASCOLT trial has achieved its highest monthly recruitment rate this quarter
  • Jul (1)
    • This month the Womens Health Study has turned positive after 18 years of follow up
  • Apr (5)
    • First investigator meeting for our new North Asia sites for the first time
    • The National Cancer Institute (U.S) has recently labelled Aspirin in Colorectal Cancer as one of the most provocative questions in cancer
    • We congratulate Dr Tham and team, and team from Sixth Affiliated Hospital
    • Zhejiang and Zhongshan hospitals obtained IRB approval
    • PIK3CA subgroup analysis included as a new secondary endpoint
  • Jan (2)
    • ASCOLT Data and Safety Monitoring Committee first meeting
    • We would also like to congratulate Sarawak General Hospital for their SIV in November and First People's Hospital of Foshan for the recruitment of their first two patients.
• 2012
  • Oct (2)
    • We are pleased to announce the study kick-off at 4 Taiwan hosptials
    • Findings: Aspirin selectively benefits CRC patients who harbour the PIK3CA mutation
  • Apr (1)
    • During this quarter, we like to congratuate Dr Abdulsalam and Dr Doaa for recruiting their first 3 patients - almost all at once - onto the study
  • Jan (1)
    • We welcome the activation of - Tata Memorial Hospital (under Dr Mohandas Mather), Severence Hospital (Dr JK Roh), and Johns Hopkins Singapore (Dr Gilberto Lopes)
• 2011
  • Oct (1)
    • Recent CAPP2 study shows that 2 yrs of daily Aspirin reduces incidence of primary colorectal cancers by 60% in patients with Lynch syndrome
  • Jul (1)
    • Site Activation of King Fahad Medical City, Phillipines General Hospital and Regional Cancer Centre
  • Apr (1)
    • The last 3 months have again been busy, and we are pleased to annouce the Activation of 5 new sites